SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-98-000525
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
12
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 336452
2 EXHIBIT 10.165 EX-10.165 164502
3 EXHIBIT 10.166 EX-10.166 40223
4 EXHIBIT 10.167 EX-10.167 135018
5 EXHIBIT 10.168 EX-10.168 193575
6 EXHIBIT 10.169 EX-10.169 111029
7 EXHIBIT 10.170 EX-10.170 62777
8 EXHIBIT 10.171 EX-10.171 2223
9 EXHIBIT 10.172 EX-10.172 3093
10 EXHIBIT 21.1 EX-21.1 533
11 EXHIBIT 23.1 EX-23.1 788
12 FINANCIAL DATA SCHEDULE EX-27.1 2214
  Complete submission text file 0000936392-98-000525.txt   1054888
Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 98581684
SIC: 2834 Pharmaceutical Preparations